Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- WLLW.TO
- Price
- 0.01
- Stock movement down
- -0.01 (-50.00%)
- Company name
- Willow Biosciences Inc
- Exchange
- (TO ,
- Currency
- CAD )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 721.02K
- Ent value
- 3.12M
- Price/Sales
- 0.39
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -94.74%
- 3 year return
- -76.07%
- 5 year return
- -60.03%
- 10 year return
- -
Last updated: 2025-04-03
DIVIDENDS
WLLW.TO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.39 |
| Price to Book | - |
| EV to Sales | 1.69 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 144.20M |
| EPS (TTM) | -0.07 |
| FCF per share (TTM) | -0.05 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 1.84M |
| Gross profit (TTM) | 200.00K |
| Operating income (TTM) | -8.88M |
| Net income (TTM) | -8.70M |
| EPS (TTM) | -0.07 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 10.87% |
| Operating margin (TTM) | -482.39% |
| Profit margin (TTM) | -472.83% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 1.24M |
| Net receivables | 13.00K |
| Total current assets | 1.71M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 1.81M |
| Total assets | 3.58M |
| Accounts payable | 645.00K |
| Short/Current long term debt | 1.88M |
| Total current liabilities | 2.43M |
| Total liabilities | 3.63M |
| Shareholder's equity | -55.00K |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -5.90M |
| Capital expenditures (TTM) | 88.00K |
| Free cash flow (TTM) | -5.99M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -243.22% |
| Return on Invested Capital | -657.10% |
| Cash Return on Invested Capital | -452.19% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 0.01 |
| Daily high | 0.01 |
| Daily low | 0.01 |
| Daily Volume | 18K |
| All-time high | 2.08 |
| 1y analyst estimate | 2.00 |
| Beta | 1.14 |
| EPS (TTM) | -0.07 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| WLLW.TO | S&P500 | |
| Current price drop from All-time high | -99.76% | -7.90% |
| Highest price drop | -99.76% | -56.47% |
| Date of highest drop | 2 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -74.75% | -11.07% |
| Avg time to new high | 71 days | 12 days |
| Max time to new high | 1040 days | 1805 days |
COMPANY DETAILS
Marketcap
721.02K
Marketcap category
Small-cap
Description
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has a collaboration agreement with SUANFARMA to develop anti-infective API through precision fermentation; and a multi-product development and licensing partnership with Laurus Labs for manufacturing active pharmaceutical ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada.
Employees
19
Website
Investor relations
-
SEC filings
CEO
Country
Canada
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a biotechnology company focused on industrial manufacturing of ingredients is pleased to announce its financial and oper...
March 25, 2025
Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a biotechnology company focused on industrial manufacturing of ingredients, announces that it has entered into a definit...
March 14, 2025
Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable...
January 20, 2025
Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable...
January 2, 2025
Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable...
November 18, 2024
Willow Biosciences Third Quarter 2024 Earnings: CA$0.01 loss per share (vs CA$0.018 loss in 3Q 2023)
Willow Biosciences ( TSE:WLLW ) Third Quarter 2024 Results Key Financial Results Revenue: CA$1.70m (up 153% from 3Q...
November 15, 2024
Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable...
November 12, 2024
Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable...
November 7, 2024
Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable ingredients, tod...
September 18, 2024
Willow Biosciences Inc. ("Willow") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable ingredients, ann...
September 5, 2024
Next page